Rubia, Katya
Johansson, Lena
Carter, Ben
Stringer, Dominic
Santosh, Paramala
Mehta, Mitul A.
Conti, Aldo Alberto
Bozhilova, Natali
Eraydin, Irem Ece
Cortese, Samuele
Funding for this research was provided by:
National Institute for Health and Care Research (NIHR130077, NIHR130077, NIHR130077, NIHR130077, NIHR130077, NIHR130077, NIHR130077, NIHR130077, NIHR130077, NIHR130077)
Article History
Received: 15 January 2024
Accepted: 1 March 2024
First Online: 30 April 2024
Declarations
:
: This trial and related trial documents have been reviewed and approved by the Medicines and Healthcare products Regulatory Agency (MHRA) (Ref: CI/2022/0003/GB), the West Midlands- Solihull Research Ethics Committee (REC) (ref: 21/WN/0169) and the Health Research Authority (HRA). Informed consent will be obtained for all subjects and their legal guardians.
: N/A.
: Professor Katya Rubia has received a grant from Takeda Pharmaceuticals. Professor Samuele Cortese declares honoraria and reimbursement for travel and accommodation expenses for lectures from the following non-profit associations: Association for Child and Adolescent Central Health (ACAMH), Canadian ADHD Alliance Resource (CADDRA), British Association of Pharmacology (BAP), and grants from NIHR (NIHR203684, NIHR203035, NIHR130077, NIHR128472, RP-PG-0618-20003European Research Agency (101095568-HORIZONHLTH-2022-DISEASE-07-03), and Solent NHS Trust (Research Capability funding, from 2018 to 2022). Professor Mitul Mehta has received research funding from Takeda Pharmaceuticals, Johnson and Johnson, Lundbeck, Boehringer Ingelheim and SoseiHeptares. Also, he acted as a consultant for Neurocrine, Lundbeck, Boehringer Ingelheim and SoseiHeptares. Professor Santosh Paramala reports grants from Anavex Life Sciences Corp, NIHR Invention for Innovation (i4i) Programme, MRC Clinical Academic Research Partnerships, NIHR HTA, NIHR EME, NIHR PGfAR, British Heart Foundation, Reverse Rett, Newron Pharmaceuticals, HealthTracker, and Anavex Life Sciences Corporation; royalties from HealthTracker; consulting fees from Anavex Life Sciences Corporation; honoraria from the Egyptian Psychiatry Association; and stocks from HealthTracker. Professor Ben Carter, Dominic Stringer, Dr Aldo Alberto Conti, Dr Natali Bozhilova, Dr Irem Ece Eraydin and Lena Johansson have no financial interest to declare.